Samsung Biologics Expands Global Footprint with Acquisition of GSK’s U.S. Facility
Rockville: Samsung Biologics, the biotech subsidiary of South Korea’s Samsung Group, has announced the acquisition of a U.S.-based manufacturing facility from GSK plc, a British